Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukaemia
Pm. Crofton et al., Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukaemia, EUR J CANC, 35(6), 1999, pp. 960-967
Children with acute lymphoblastic leukaemia (ALL) have reduced bone turnove
r caused by the disease itself and early intensive chemotherapy, but the ef
fects of later chemotherapy using different drug combinations are uncertain
. We report here a longitudinal study on 9 children with ALL randomised to
receive an additional third intensification block of chemotherapy, compared
with 9 children receiving continuing chemotherapy over the same period. Du
ring third intensification, bone alkaline phosphatase, procollagen type I C
-terminal propeptide, the carboxyterminal propeptide of type I collagen, pr
ocollagen type III N-terminal propeptide and lower leg length all decreased
in response to dexamethasone, then returned to (but not beyond) baseline l
evels after dexamethasone was stopped and other drugs started. These change
s were unrelated to circulating insulin-like growth factor (IGF)I, IGF bind
ing protein (IGFBP)-3 or IGFBP-2. In all children, bone alkaline phosphatas
e remained below the population mean throughout. We conclude that dexametha
sone decreased bone and soft tissue turnover, probably through direct effec
ts on target tissues. The postdexamethasone phase of third intensification
and continuing chemotherapy had no major deleterious effect on collagen tur
nover, but there was evidence of continuing suboptimal bone mineralisation.
(C) 1999 Elsevier Science Ltd. All rights reserved.